Teva to Present at the 2013 Barclays Global Healthcare Conference Barclays Global Healthcare Conference 2013 Business Wire JERUSALEM -- March 12, 2013 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 2013 Barclays Global Healthcare Conference. Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd. will present on Thursday, March 14, 2013. What: Teva Presentation at the Barclays Global Healthcare Conference Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd. When: Thursday, March 14, ^ 2013 at 9:30 AM (EDT) Where: www.tevapharm.com Live over the Internet – log on to the Web at the address above and How: register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. Contact: Teva IR: United States Kevin C. Mannix, 215-591-8912 Kristen Frank, 215-591-8908 or Israel Tomer Amitai, 972 (3) 926-7656 or Media: Israel Hadar Vismunski-Weinberg, 972 (3) 926-7687 or United States Denise Bradley, 215-591-8974
Teva to Present at the 2013 Barclays Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.